FDAFDA · Food and drugs·Recall number D-1171-2023
Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93
Published September 27, 2023 · Recall initiated: August 2, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications - results obtained were below spec average.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- USA nationwide
- Lot
- Lot #: 3112444, Exp 8/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.